Please login to the form below

Not currently logged in
Email:
Password:

dimethyl fumarate

This page shows the latest dimethyl fumarate news and features for those working in and with pharma, biotech and healthcare.

Dismay as NICE rejects Roche’s MS drug Ocrevus

Dismay as NICE rejects Roche’s MS drug Ocrevus

such as Novartis’Gilenya (fingolimod) and Biogen’s Tecfidera (dimethyl fumarate).

Latest news

More from news
Approximately 12 fully matching, plus 44 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2017 Deal Watch January 2017

    Biogen. Patent settlement. Tecfidera (dimethyl fumarate). 1, 250. Merrimack Pharamceuti-cals. Ipsen.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Executive vice president of Biogen leaves Executive vice president of Biogen leaves

    Kingsley joined Biogen in 2010 as senior VP and during his tenure Biogen introduced five new therapies including successfully launching Tecfidera (dimethyl fumarate) – the most prescribed oral treatment for multiple sclerosis.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics